Featured Post

Latest Gold News

Weak dollar, equities supporting gold Trump remains unimpressed with NAFTA   Business cycle winding down says Wall Street banks Klon...

Tuesday, December 20, 2011

Watson (WPI) (XLNX) (BBBY) (DXCM) (ERF) (TRGT) Ratings, Price Targets

Watson Pharmaceuticals Incorporated (NYSE: WPI), Xilinx, Inc. (NASDAQ: XLNX), Bed Bath & Beyond Inc. (NASDAQ: BBBY), DexCom Inc. (NASDAQ: DXCM), Enerplus Resources Fund (NYSE: ERF) and Targacept Inc. (NASDAQ: TRGT) ratings and price targets.

Needham & Company reiterated its "Hold" rating on Watson Pharmaceuticals Incorporated (WPI).

Credit Suisse (NYSE:CS) reiterated its "Neutral" rating on Xilinx, Inc. (XLNX). They have a price target of $35.00 on the company.

Jefferies (NYSE:JEF) reiterated its "Buy" rating on Bed Bath & Beyond Inc. (BBBY).

McNicoll Lewis & Vlak initiated coverage on DexCom Inc. (DXCM). They placed a “Buy” rating on the company.

Credit Suisse initiated coverage on Enerplus Resources Fund (ERF). They placed a “Neutral” rating and a price target of $28.00 on the company.

Targacept Inc. (NASDAQ: TRGT) was downgraded by Leerink from an “Outperform” rating to a “Market Perform” rating.

No comments: